Incyte INCY
NASDAQ INCY
$122.27 +1.97 (+1.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Incyte (INCY) Non Operating Income (2011 - 2012)

Updated

Analysis

Incyte (INCY) Non Operating Income (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Incyte 245.42 Mn -15.74 Bn 1.45 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 52,000.00
Mar 31, 2011 72,000.00
API Access

Incyte Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=INCY&period=max&api_key=YOUR_API_KEY